Preimplantation genetic testing market was estimated to be worth USD 0.8 billion in 2023, and during the 2024–2034 forecast period, it is expected to grow at a compound annual growth rate (CAGR) of 12.5% to reach USD 2.2 billion. By choosing embryos devoid of genetic defects, preimplantation genetic testing dramatically raises the likelihood of a fruitful pregnancy and the birth of a healthy kid. The market is increasing and sustainable since it is in line with the healthcare industry.
Preimplantation genetic testing (PGT) is a medical method that identifies defective embryos early on in the prenatal genetic diagnosis process, allowing genetically normal embryos to be transferred. Procedures involving assisted reproductive technology (ART) now include this technology as a necessary component. The process entails examining embryos for distinct genetic disorders or chromosomal irregularities to guarantee that solely sound embryos are inserted into the uterus.

Request For Free Sample Pages @ https://www.xresearch.biz/request-sample-pages/preimplantation-genetic-testing-market

GROWTH DRIVERS
One of the main factors propelling the market is the rise in the prevalence of chromosomal abnormalities and genetic disorders. In developed nations, congenital anomalies and genetic illnesses may account for as much as 50% of childhood fatalities. Additionally, up to 30% of pediatric hospital hospitalizations may be related to these illnesses. An estimated 240 000 infants worldwide pass away from congenital diseases within 28 days of birth each year.
Maternal age is rising due to the tendency of delayed motherhood, particularly in industrialized nations, and this is linked to a higher risk of chromosomal problems. Preimplantation genetic testing (PGT) is frequently advised for women over 35, according to NCBI, because chromosomal abnormalities in embryos might be significantly influenced by advanced maternal age. One of the main elements driving the industry is the worldwide rates of infertility caused by things like delayed childbirth, changes in lifestyle, and environmental variables.
The substantial growth in government health spending across all national income levels is responsible for the surge in health spending to a record high of USD 9 trillion, or over 11% of the world's gross domestic product. The promotion of PGT was greatly aided by the activism of patient groups and professional associations.
MARKET SEGMENTATION:
· By Product & Services- reagent and consumables, instruments, software and services
· By Procedure Type- Preimplantation Genetic Diagnosis & Preimplantation Genetic Screening
· By Technology- Next-Generation Sequencing, Fluorescence In-Situ Hybridization, Polymerase Chain Reaction, Comparative Genomic Hybridization and Single-Nucleotide Polymorphism
· By Application- Structural Chromosomal Abnormalities (Translocations, Deletions, Inversions, Duplication), Aneuploidy, Gender Identification, Single Gene Disorders, X-Linked Disorders, HLA Typing
· By Type of Cycle- Fresh Donor, Fresh Non- Donor, Frozen Donor, Frozen Non-Donor
· By End-User- Hospitals, Diagnostic Laboratories, Fertility Clinics
· By Region- North America, Europe, Asia Pacific, The Middle East and Africa, South America
Global Key Players:
· Illumina, Inc.
· Thermo Fisher Scientific Inc.
· CooperSurgical, Inc.
· Agilent Technologies, Inc.
· Revvity
· Abbott
· Takara Bio, Inc.
· Qiagen
· Vitrolife
· Oxford Nanopore Technologies
· Bioarray S.L.
· Other Players

For More Information about this Report @ https://www.xresearch.biz/shop/preimplantation-genetic-testing-market

About Us: -
xResearch is a market research and consulting organization that uses unique data, expert analysis, and new technologies to create trusted intelligence on industries. Our research is focused on delivering an informed and impartial view on essential market data of industry, and it is primarily driven by an in-depth study covering the following parameters: Market Sizing and Forecasting, Market Segmentation, Competitive Analysis, Strategic Assessment and Business Modelling.

Contact:
Company Name: xResearch
Contact Person: James Lin
Email: [email protected]
Phone: +1 718-619-8140